Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimdazenil Observational Study in Stroke-Related Insomnia
ChiCTR2600129864Phase 4Not yet recruiting
- Sponsor
- PKU Healthcare
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dimdazenil in Insomnia, sponsored by PKU Healthcare. Primary endpoint: Subjective Total Sleep Time. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
dimdazenil
03
Conditions
Insomnia
Beyond the preview
Go deeper on ChiCTR2600129864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600129864.